Ngā hua rapu - Eeles, R A

BRCA1, BRCA2 and their possible function in DNA damage response mā Kote-Jarai, Z, Eeles, R A

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Management of Breast Cancer in BRCA1/2 Mutation Carriers mā Eeles, R. A., Camplejohn, R., Peacock, J., McMillan, T.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Non-Hodgkin's lymphoma presenting with extradural spinal cord compression: functional outcome and survival. mā Eeles, R. A., O'Brien, P., Horwich, A., Brada, M.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriers mā Kadouri, L, Kote-Jarai, Z, Hubert, A, Baras, M, Abeliovich, D, Hamburger, T, Peretz, T, Eeles, R A

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers mā Kadouri, L, Kote-Jarai, Z, Hubert, A, Durocher, F, Abeliovich, D, Glaser, B, Hamburger, T, Eeles, R A, Peretz, T

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Ambiguity in a masculine world: Being a BRCA1/2 mutation carrier and a man with prostate cancer mā Moynihan, C., Bancroft, E.K., Mitra, A., Ardern‐Jones, A., Castro, E., Page, E.C., Eeles, R.A.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Cowden syndrome and Lhermitte-Duclos disease in a family: a single genetic syndrome with pleiotropy? mā Eng, C, Murday, V, Seal, S, Mohammed, S, Hodgson, S V, Chaudary, M A, Fentiman, I S, Ponder, B A, Eeles, R A

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers mā Kadouri, L, Easton, D F, Edwards, S, Hubert, A, Kote-Jarai, Z, Glaser, B, Durocher, F, Abeliovich, D, Peretz, T, Eeles, R A

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Head and neck sarcomas: prognostic factors and implications for treatment. mā Eeles, R. A., Fisher, C., A'Hern, R. P., Robinson, M., Rhys-Evans, P., Henk, J. M., Archer, D., Harmer, C. L.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters. The CRC/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign/British... mā Edwards, S. M., Dearnaley, D. P., Ardern-Jones, A., Hamoudi, R. A., Easton, D. F., Ford, D., Shearer, R., Dowe, A., Eeles, R. A.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

The value of rapid functional assays of germline p53 status in LFS and LFL families mā Camplejohn, R S, Sodha, N, Gilchrist, R, Lomax, M E, Duddy, P M, Miner, C, Alarcon-Gonzalez, P, Barnes, D M, Eeles, R A

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

CHEK2 variants in susceptibility to breast cancer and evidence of retention of the wild type allele in tumours mā Sodha, N, Bullock, S, Taylor, R, Mitchell, G, Guertl-Lackner, B, Williams, R D, Bevan, S, Bishop, K, McGuire, S, Houlston, R S, Eeles, R A

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Hormone replacement therapy and survival after surgery for ovarian cancer. mā Eeles, R A, Tan, S, Wiltshaw, E, Fryatt, I, A'Hern, R P, Shepherd, J H, Harmer, C L, Blake, P R, Chilvers, C E

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Allelic imbalance in familial and sporadic prostate cancer at the putative human prostate cancer susceptibility locus, HPC1. CRC/BPG UK Familial Prostate Cancer Study Collaborators... mā Dunsmuir, W. D., Edwards, S. M., Lakhani, S. R., Young, M., Corbishley, C., Kirby, R. S., Dearnaley, D. P., Dowe, A., Ardern-Jones, A., Kelly, J., Eeles, R. A.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Apoptosis, ageing and cancer susceptibility mā Camplejohn, R S, Gilchrist, R, Easton, D, McKenzie-Edwards, E, Barnes, D M, Eccles, D M, Ardern-Jones, A, Hodgson, S V, Duddy, P M, Eeles, R A

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease mā Meitz, J C, Edwards, S M, Easton, D F, Murkin, A, Ardern-Jones, A, Jackson, R A, Williams, S, Dearnaley, D P, Stratton, M R, Houlston, R S, Eeles, R A

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Germline PTEN mutations in Cowden syndrome-like families. mā Marsh, D J, Dahia, P L, Caron, S, Kum, J B, Frayling, I M, Tomlinson, I P, Hughes, K S, Eeles, R A, Hodgson, S V, Murday, V A, Houlston, R, Eng, C

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Processing of radical prostatectomy specimens for correlation of data from histopathological, molecular biological, and radiological studies: a new whole organ technique mā Jhavar, S G, Fisher, C, Jackson, A, Reinsberg, S A, Dennis, N, Falconer, A, Dearnaley, D, Edwards, S E, Edwards, S M, Leach, M O, Cummings, C, Christmas, T, Thompson, A, Woodhouse, C, Sandhu, S, Cooper, C S, Eeles, R A

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

ATM polymorphisms as risk factors for prostate cancer development mā Angèle, S, Falconer, A, Edwards, S M, Dörk, T, Bremer, M, Moullan, N, Chapot, B, Muir, K, Houlston, R, Norman, A R, Bullock, S, Hope, Q, Meitz, J, Dearnaley, D, Dowe, A, Southgate, C, Ardern-Jones, A, Easton, D F, Eeles, R A, Hall, J

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Hand pattern indicates prostate cancer risk mā Rahman, A A, Lophatananon, A, Stewart-Brown, S, Harriss, D, Anderson, J, Parker, T, Easton, D, Kote-Jarai, Z, Pocock, R, Dearnaley, D, Guy, M, O'Brien, L, Wilkinson, R A, Hall, A L, Sawyer, E, Page, E, Liu, J-F, Eeles, R A, Muir, K

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa